42 / 112
40
Scientific Programme
|
Monday, 15 June 2015
WFSBP 2015
P-05-009
Valerian, melissa, passion flower and their combination
STW 32 in experimental models of anxiety
Jürgen Müller, Germany
S. N. Okpanyi, O. Kelber, C. Kolb
P-05-010
Valerian: Safety confirmed
J. Müller, Germany
K. Kraft, O. Kelber, K. Nieber
P-05-011
BDNF gene in bipolar disorder: Case-control association
study in South Indian sample and relationship to lithium
treatment response
Ravi Kumar Nadella, India
P. Paul, S. Sen, L. N. Kota, V. Kapur, G. Saraf, B. Viswanath,
M. Purushottam, M. D. Zompo, A. Squassina, S. Jain
P-05-012
Genetic variants in telomerase-pathway genes are associ-
ated with antidepressant response
Sandra Scheuer, Germany
T. Brückl, H. Pfister, M. Uhr, S. Kloiber, S. Lucae, F. Wilhelm,
M. Ising
P-05-013
Transcranial magnetic stimulation at 5Hz as an antide-
pressant response accelerator: Clinical and QEEG analysis
Jorge Julio González Olvera, Mexico
E. Reyes Zamorano, J. Ricardo Garcell, E. Miranda-Terres,
M. d. Lourdes García-Anaya, F. Pellicer-Graham
P-05-014
Repetitive Transcranial Magnetic Stimulation modifies the
neural processing of emotional stimuli
Virginie Moulier, France
C. Gaudeau, N. Bouaziz, M. Thomas, P. Schenin-King Andri-
anisaina, E. Bertasi, D. Januel
P-05-015
Clinical effectiveness of electroconvulsive therapy in a uni-
versity hospital setting in South Korea
Hee-Cheol Kim, Republic of Korea
Y.-M. Choi, K.-S. Kim
P-06
Poster Presentation
12:45–14:15
Muses Foyer
Genetics/Cognitive Neuroscience/Neuroimaging
Chair:
Dimitris Dikeos, Greece
Co-Chair: Evgenia Daskalopoulou, Greece
P-06-001
Anti-social behaviour neurobiology
Guillermo Nicolas Jemar, Argentina
P-06-002
The effect of cross-sex hormone treatment on resting state
functional connectivity in transsexuals assessed using net-
work-based statistics
Marie Spies, Austria
A. Hahn, G. Kranz, M. Küblböck, H. Allan, S. Ganger, K. Ulrike,
C. Windischberger, D. Winkler, S. Kasper, R. Lanzenberger
P-06-003
The role of peripheral tumor necrosis factor genes in cog-
nitive deficits–preliminary study
Piotr Galecki, Poland
M. Talarowska
P-06-004
Brexpiprazole, a novel serotonin-dopamine activity modu-
lator, has the beneficial effects on NMDA related cognitive
dysfunction model in mice: Novel object recognition test
in chronic PCP model
Noriko Yoshimi, Japan
K. Hashimoto, Y. Fujita, Y. Ohgi, T. Futamura, T. Kikuchi
P-06-005
Brexpiprazole, a novel serotonin-dopamine activity modu-
lator, has the beneficial effects on NMDA related cognitive
dysfunction model in mice: Social recognition test in acute
dizocilpine model
Noriko Yoshimi, Japan
T. Futamura, T. Kikuchi, K. Hashimoto
P-06-006
Comparison of facial emotion recognition deficits and cere-
bral laterality in patients with schizophrenia versus bipolar
disorder, their first degree relatives and healthy controls
Rishikesh Behere, India
U. Thonse, P. Sharma
P-06-007
Social brain activity during theory of mind in first episode
psychosis: Comparison with healthy controls and link to
symptoms
Cali Bartholomeusz, Australia
E. Ganella, S. Whittle, A. Abu-Akel, K. Allott, A. Thompson,
P. McGorry, E. Killackey, C. Pantelis, S. J. Wood